Newsletter | July 22, 2020

07.22.20 -- Meet Increased Performance And Scale For COVID-19 Bioprocessing

Cold-Chain Bioprocessing: Mitigate Risk, Protect Biopharma Products

Many monoclonal antibodies (mAbs), vaccines, and other biotherapeutics must be reliably stored and transported at subzero temperatures, requiring a robust cold chain that continues throughout downstream processing. This article demonstrates how proper implementation of single-use technology is the key to success.

Single-Use Fluoropolymer Bags For Efficient High-Density Cell Banking

The need for rapid development and scale-up of vaccines and therapeutics has never been greater. But conventional seed train processes used to amplify cells from cell cultures are inefficient and subject to risk. This article explains how single-use bags perform during freezing, storage, and thawing steps and why they present an efficient alternative to vials in a variety of upstream cell banking applications.

Risk Mitigation For Single-Use Cold Chain Distribution

This webinar shares risk mitigation study data showing the utility of low temperature suitable materials and packaging, employment of sensors for monitoring shipments, and better qualification and evaluation through simulated standards and real-world transit.

High-Density Cell Banking

High-density cell banking accelerates the upstream process by providing a much larger volume of concentrated cells at the start of a production run. Watch this webinar to find out how to jump-start your bioreactor and shorten the seed training process from weeks to days.